Clinical Trials Directory

Trials / Unknown

UnknownNCT02501993

Nasopharyngeal Carcinoma Screening in Zhongshan City

Serology Screening Test for the Detection of Nasopharyngeal Carcinoma in Zhongshan City

Status
Unknown
Phase
Study type
Observational
Enrollment
25,000 (estimated)
Sponsor
Zhongshan People's Hospital, Guangdong, China · Academic / Other
Sex
All
Age
30 Years – 59 Years
Healthy volunteers
Accepted

Summary

The primary objective is to determine the early diagnosis rate and mortality rate of the Nasopharyngeal Carcinoma (NPC) in the study population. The secondary objective is to determine the incidence of NPC in the study population.

Detailed description

The research is to evaluate the effect of NPC screening, also as an extended study of Screening for Nasopharyngeal Carcinoma in High Risk Populations (NCT00941538). The program was conducted in Xiaolan and Minzhong towns of Zhongshan city in 2012. All participants will be tested for anti-EBV antibody by using serum samples. Participants are stratified into those having high, moderate and low antibody levels, those having moderate antibody levels are invited to retest annually in the following 3 years and those found to have high antibody levels on these occasions are referred to centers for diagnostic workup for NPC.

Conditions

Timeline

Start date
2012-03-01
Primary completion
2019-12-01
Completion
2023-12-01
First posted
2015-07-17
Last updated
2023-07-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02501993. Inclusion in this directory is not an endorsement.

Nasopharyngeal Carcinoma Screening in Zhongshan City (NCT02501993) · Clinical Trials Directory